Protocol for the systematic reviews on the desirable and undesirable effects of pharmacological treatments of allergic rhinitis informing the ARIA 2024 guidelines
Rafael José Vieira¹,², Maria Inês Torres¹,², Antonio Bognanni³,⁴, Sara Gil-Mata¹,², Renato Ferreira-da-Silva¹,², Nuno Lourenço-Silva¹,², António Cardoso-Fernandes¹,², André Ferreira²,⁵,⁶, Henrique Ferreira-Cardoso¹,², João Teles¹,², Miguel Campos-Lopes¹,², João A. Fonseca¹,², Juan José Yepes-Nuñez³,⁷, Ludger Klimek⁸,⁹, Torsten Zuberbier¹⁰,¹¹, Holger Schünemann³, Jean Bousquet¹⁰,¹¹,¹², Bernardo Sousa-Pinto¹,^2
1 MEDCIDS – Department of Community Medicine, Information and Health Decision Sciences, ² CINTESIS@RISE – Health Research Network, MEDCIDS, Faculty of Medicine, University of Porto, Porto, Portugal, ³ Department of Health Research Methods, Evidence and Impact, ⁴ Department of Medicine, Evidence in Allergy Group, McMaster University, Hamilton, ON, Canada, ⁵ Unit of Anatomy, Department of Biomedicine, Faculty of Medicine, University of Porto, ⁶ Department of Ophthalmology, Centro Hospitalar Universitário do Porto, Porto, Portugal, ⁷ School of Medicine, Universidad de los Andes, Bogotá, Colombia, ⁸ Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, ⁹ Center for Rhinology and Allergology, Wiesbaden, ^{1  0} Institute of Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, ^{1  1} Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany, and ^{1  2} ARIA, Montpellier, France